World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
49
Citations
15188
World Ranking
17842
National Ranking
7302

Richard A. Franklin publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Richard A. Franklin sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 109 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Richard A. Franklin D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Richard A. Franklin sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 49 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Richard A. Franklin is affiliated with East Carolina University in the United States. Their research spans several areas within medicine and biochemistry, with a focus on oncology, molecular biology, and plant science. The scientist's work addresses various aspects of cancer biology, molecular pathways related to cancer, and the biological activity of phytochemical compounds.

Franklin has contributed to multiple research papers, including studies on anticancer effects, cancer cell metabolism, and the application of plant extracts in cancer treatment. Notable publications include:

  • Anti-cancer effects of green synthesized gold nanoparticles using leaf extract of Annona muricata. L against squamous cell carcinoma cell line 15 through apoptotic pathway, 2024, Dental Research Journal
  • Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties, 2022, Aging
  • Evaluation of the cytotoxic, anti-proliferative, anti-metastatic and pro-apoptotic effect of aqueous leaf extract of Annona muricata on oral tongue squamous cell carcinoma cell line (SCC-15): An in vitro study, 2023, Journal of Oral and Maxillofacial Pathology
  • Salivary duct carcinoma in the submandibular gland: A rare case report with differential diagnosis, 2024, Journal of Oral and Maxillofacial Pathology
  • Unveiling the Mysteries of Ameloblastoma: A Comprehensive Case Series on Odontogenic Lesions, 2025, Journal of Pharmacy And Bioallied Sciences

Frequent coauthors in Franklin's work include:

  • Prasanth Thankappan
  • S. Jeslin Mary
  • Veeran Veeravarmal
  • D Angelin
  • Paramasivam Arumugam

The scientist's work has appeared most often in the following venues:

  • Journal of Oral and Maxillofacial Pathology
  • Dental Research Journal
  • Aging
  • Journal of Pharmacy And Bioallied Sciences

Richard A. Franklin's main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within their research, subfields of interest are:

  • Oncology
  • Biochemistry
  • Molecular Biology
  • Plant Science
  • General Health Professions

Key research topics addressed by Franklin focus on:

  • Traditional and Medicinal Uses of Annonaceae
  • Moringa oleifera research and applications
  • Diverse Scientific Research Studies
  • Pancreatic and Hepatic Oncology Research
  • Cancer-related Molecular Pathways
  • Cancer, Hypoxia, and Metabolism
  • Phytochemical compounds biological activities

Best Publications

  • ROLES OF THE RAF/MEK/ERK PATHWAY IN CELL GROWTH, MALIGNANT TRANSFORMATION AND DRUG RESISTANCE

    James A. McCubrey;Linda S. Steelman;William H. Chappell;Stephen L. Abrams

  • Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy

    F Chang;J T Lee;P M Navolanic;L S Steelman

  • Reactive oxygen species-induced activation of the MAP kinase signaling pathways.

    James A. McCubrey;Michelle M. LaHair;Richard A. Franklin

  • Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention

    F Chang;L S Steelman;J T Lee;J G Shelton

  • JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.

    L S Steelman;S C Pohnert;J G Shelton;Richard A Franklin

  • Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.

    James A. McCubrey;Linda S. Steelman;Steven L. Abrams;John T. Lee

  • Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health

    William H. Chappell;Linda S. Steelman;Jacquelyn M. Long;Ruth C. Kempf

  • Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review)

    Fumin Chang;Linda S. Steelman;John G. Shelton;John T. Lee

  • Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance

    James Andrew McCubrey;Linda S. Steelman;William H. Chappell;Stephen L. Abrams

  • Roles of the Ras/Raf/MEK/ERK pathway in leukemia therapy.

    L S Steelman;R A Franklin;S L Abrams;W Chappell

  • Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle

    Naohiro Terada;Joseph J. Lucas;Agota Szepesi;Richard A. Franklin

  • Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells : possible sites for intervention with anti-neoplastic drugs

    W. L. Blalock;C. Weinstein-Oppenheimer;C. Weinstein-Oppenheimer;F. Chang;P. E. Hoyle

  • Kinases: positive and negative regulators of apoptosis

    R A Franklin;J A McCubrey

  • Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors.

    Linda S. Steelman;Patrick M. Navolanic;Melissa L. Sokolosky;Jackson R. Taylor

  • Redox regulation of the calcium/calmodulin-dependent protein kinases.

    Christopher J. Howe;Michelle M. LaHair;James A. McCubrey;Richard A. Franklin

  • Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes.

    Richard A. Franklin;Attila Tordai;Hiren Patel;Anne M. Gardner

  • Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells

    JA McCubrey;LS Steelman;PE Hoyle;WL Blalock

  • Effects of the RAF/MEK/ERK and PI3K/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells

    John G Shelton;Linda S Steelman;John T Lee;Steven L Knapp

  • Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin.

    Caroline R. Weinstein-Oppenheimer;Carlos F. Henríquez-Roldán;Julianne M. Davis;Patrick M. Navolanic

  • Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism.

    P E Hoyle;P W Moye;L S Steelman;W L Blalock

Frequent Co-Authors

James A. McCubrey
James A. McCubrey East Carolina University
Massimo Libra
Massimo Libra University of Catania
Alberto M. Martelli
Alberto M. Martelli University of Bologna
Erwin W. Gelfand
Erwin W. Gelfand University of Colorado Anschutz Medical Campus
Martin McMahon
Martin McMahon Huntsman Cancer Institute
Michele Milella
Michele Milella University of Verona
Naohiro Terada
Naohiro Terada University of Florida
Lucio Cocco
Lucio Cocco University of Bologna
Keith W. Kelley
Keith W. Kelley University of Illinois at Urbana-Champaign
Giuseppe Montalto
Giuseppe Montalto University of Palermo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Biology or Biochemistry opens up a wide range of opportunities in healthcare, research, and the life sciences. For students looking for flexibility, online degree programs can offer affordable and accelerated pathways to professional roles. For example, if you’re interested in the intersection of biology and nutrition, consider pursuing an online nutrition degree. This is an excellent option for those who wish to promote healthy living or work in clinical environments.

Many biology majors continue their education in nursing. There are cheapest rn to bsn online programs that make it convenient for registered nurses to advance without breaking the bank. If your interests lead toward healthcare management, you may want to look into the fastest online mha programs to accelerate your leadership career.

Additionally, for those seeking advanced clinical practice, becoming a nurse practitioner is an attractive path. The fastest psych np program lets you focus on mental health—a growing field that values a strong background in biology and human sciences. With so many related options, online education makes it easier than ever to tailor your degree toward your ideal career pathway.

Best Scientists Citing Richard A. Franklin

Trending Scientists

Recently Published Articles